Wolverine Asset Management’s Synergy Pharmaceuticals SGYP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-236,406
Closed -$26K – 1872
2018
Q4
$26K Hold
236,406
– – ﹤0.01% 1475
2018
Q3
$401K Hold
236,406
– – ﹤0.01% 1070
2018
Q2
$411K Sell
236,406
-3,200
-1% -$5.53K 0.01% 984
2018
Q1
$438K Buy
+239,606
New +$506K 0.01% 1009
2014
Q1
– Sell
-153,211
Closed -$850K – 2925
2013
Q4
$850K Buy
153,211
+63,815
+71% +$275K 0.02% 578
2013
Q3
$402K Buy
+89,396
New +$401K 0.01% 852

Other funds holding SGYP

Wolverine Asset Management's SGYP Position: Q1 2019 in Review

Wolverine Asset Management sold out of Synergy Pharmaceuticals (SGYP) in Q1 2019, closing a stake of 236,406 shares — an estimated $26K sold.

Wolverine Asset Management first reported a position in SGYP in Q3 2013 and held it in 6 quarters. The position peaked at $850K in Q4 2013. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

  • Wolverine Asset Management reported no remaining Synergy Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Wolverine Asset Management sold 236,406 Synergy Pharmaceuticals shares in Q1 2019, an estimated $26K.
  • Wolverine Asset Management first reported a position in Synergy Pharmaceuticals in Q3 2013 and held it in 6 quarters.
  • Wolverine Asset Management's Synergy Pharmaceuticals position peaked at $850K in Q4 2013.
  • 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals as of Q1 2019.

Based on Wolverine Asset Management's 13F filing for Q1 2019, filed 15 May 2019.